Increase in immunogenicity with concomitant loss of tumorigenicity of respiratory tract carcinomas during in vitro culture
- PMID: 87265
Increase in immunogenicity with concomitant loss of tumorigenicity of respiratory tract carcinomas during in vitro culture
Abstract
Cell lines were established in vitro from respiratory tract carcinomas induced in rats by carcinogenic, polycyclic hydrocarbons. Propagation of the carcinoma lines in vitro lead to a progressive decrease in tumorigenicity. Tumor transplantation studies in X-irradiated, immunosuppressed recipients and in immunologically reconstituted recipients suggested that the cells are rejected because of their immunogenicity, since a high incidence of tumors was observed in X-irradiated recipients but not in normal or X-irradiated, reconstituted recipients. When immunologically competent rats were immunized with cells from an in vitro tumor line, strong tumor transplantation resistance resulted. Similar immunization with the corresponding in vivo tumor line caused very little if any protection, and immunization with a non-cross-reacting sarcoma line grown in vitro did not produce immunological protection against carcinoma cell lines. A single in vivo passage of the in vitro-adapted tumor line in immunosuppressed recipients fully restored tumorigenicity. The increase in immunogenicity of carcinomas cultured in vitro appears to involve preexisting angigens indigenous to the carcinomas rather than new antigens acquired during tissue culture, such as antigens related to retroviruses, mycoplasmas, or heterologous serum.
Similar articles
-
Demonstration of cross-reacting tumor rejection antigens in chemically induced respiratory tract carcinomas in rats.Cancer Res. 1977 Nov;37(11):4059-63. Cancer Res. 1977. PMID: 71203
-
Demonstration of cellular and humoral immunity to transplantable carcinomas derived from the respiratory tract of rats.Cancer Res. 1978 Feb;38(2):261-7. Cancer Res. 1978. PMID: 340026
-
Prevention of tumors in rats by cross-protective immunization.J Natl Cancer Inst. 1981 Nov;67(5):1041-51. J Natl Cancer Inst. 1981. PMID: 6946246
-
Common tumor rejection antigens in methylcholanthrene-induced squamous cell carcinomas of mice detected by tumor protection and a radioisotopic footpad assay.Cancer Res. 1977 Jan;37(1):37-41. Cancer Res. 1977. PMID: 63329
-
Increase in immunogenicity of a pulmonary squamous-cell carcinoma, propagated in vitro.Int J Cancer. 1977 Dec 15;20(6):817-23. doi: 10.1002/ijc.2910200602. Int J Cancer. 1977. PMID: 591125
Cited by
-
Implications of tumor progression on clinical oncology.Clin Exp Metastasis. 1985 Jul-Sep;3(3):151-88. doi: 10.1007/BF01786761. Clin Exp Metastasis. 1985. PMID: 3902300 Review. No abstract available.
-
The effect of passage in vitro and in vivo on the properties of murine fibrosarcomas I. Tumorigenicity and immunogenicity.Br J Cancer. 1985 Feb;51(2):161-9. doi: 10.1038/bjc.1985.25. Br J Cancer. 1985. PMID: 3966976 Free PMC article.
-
Dynamic heterogeneity: experimental metastasis studies with RIF-1 fibrosarcoma.Clin Exp Metastasis. 1989 Jan-Feb;7(1):107-16. doi: 10.1007/BF02057185. Clin Exp Metastasis. 1989. PMID: 2908825
-
Epitope masking of rat esophageal carcinoma tumor-associated antigen by certain coexisting glycolipid and phospholipid molecules: a potential mechanism for tumor cell escape from the host immune responses.Cancer Immunol Immunother. 1994 Feb;38(2):99-106. doi: 10.1007/BF01526204. Cancer Immunol Immunother. 1994. PMID: 7508339 Free PMC article.